PPN20- ESTIMATED RESOURCE USE AND COST OF MITOXANTRONE VS PLACEBO IN PATIENTS WITH PROGRESSIVE-RELAPSING AND SECONDARY-PROGRESSIVE MULTIPLE SCLEROSIS- RESULTS FROM THE MIMS TRIAL
Sep 1, 2001, 00:00
10.1046/j.1524-4733.2001.40202-242.x
https://www.valueinhealthjournal.com/article/S1098-3015(11)71399-7/fulltext
Title :
PPN20- ESTIMATED RESOURCE USE AND COST OF MITOXANTRONE VS PLACEBO IN PATIENTS WITH PROGRESSIVE-RELAPSING AND SECONDARY-PROGRESSIVE MULTIPLE SCLEROSIS- RESULTS FROM THE MIMS TRIAL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71399-7&doi=10.1046/j.1524-4733.2001.40202-242.x
First page :
Section Title :
Open access? :
No
Section Order :
291